Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.
Caccese M, Desideri I, Villani V, Simonelli M, Buglione M, Chiesa S, Franceschi E, Gaviani P, Stasi I, Caserta C, Brugnara S, Lolli I, Bennicelli E, Bini P, Cuccu AS, Scoccianti S, Padovan M, Gori S, Bonetti A, Giordano P, Pellerino A, Gregucci F, Riva N, Cinieri S, Internò V, Santoni M, Pernice G, Dealis C, Stievano L, Paiar F, Magni G, De Salvo GL, Zagonel V, Lombardi G. Caccese M, et al. Among authors: paiar f. ESMO Open. 2024 Apr;9(4):102943. doi: 10.1016/j.esmoop.2024.102943. Epub 2024 Mar 15. ESMO Open. 2024. PMID: 38492275 Free PMC article.
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.
Pasqualetti F, Pace A, Gonnelli A, Villani V, Cantarella M, Delishaj D, Vivaldi C, Molinari A, Montrone S, Pellerino A, Franchino F, Baldaccini D, Lombardi G, Lolli I, Catania F, Bazzoli E, Morganti R, Fabi A, Zagonel V, Bocci G, Fabrini MG, Rudà R, Soffietti R, Paiar F. Pasqualetti F, et al. Among authors: paiar f. Am J Clin Oncol. 2018 Dec;41(12):1272-1275. doi: 10.1097/COC.0000000000000464. Am J Clin Oncol. 2018. PMID: 29782366
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study.
Procopio G, Chiuri VE, Giordano M, Alitto AR, Maisano R, Bordonaro R, Cinieri S, Rossetti S, De Placido S, Airoldi M, Galli L, Gasparro D, Ludovico GM, Guglielmini PF, Carella C, Nova P, Aglietta M, Schips L, Beccaglia P, Sciarra A, Livi L, Santini D; ABItude Study Group. Procopio G, et al. ESMO Open. 2022 Apr;7(2):100431. doi: 10.1016/j.esmoop.2022.100431. Epub 2022 Apr 8. ESMO Open. 2022. PMID: 35405438 Free PMC article.
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?
Villani V, Fabi A, Tanzilli A, Pasqualetti F, Lombardi G, Vidiri A, Gonnelli A, Molinari A, Cantarella M, Bellu L, Terrenato I, Carosi M, Maschio M, Telera SM, Carapella CM, Cognetti F, Paiar F, Zagonel V, Pace A. Villani V, et al. Among authors: paiar f. Future Oncol. 2019 May;15(15):1717-1727. doi: 10.2217/fon-2018-0826. Epub 2019 Apr 12. Future Oncol. 2019. PMID: 30977687
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies.
Bonomo P, Cipressi S, Desideri I, Masi L, Doro R, Iermano C, Greto D, Simontacchi G, Mangoni M, Paiar F, Meattini I, Scoccianti S, Santoro G, Valente S, Gensini GF, Livi L. Bonomo P, et al. Among authors: paiar f. Tumori. 2015 May-Jun;101(3):294-7. doi: 10.5301/tj.5000280. Epub 2015 Apr 13. Tumori. 2015. PMID: 25908042
Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 Trial.
Maddalo M, Borghetti P, Tomasini D, Corvò R, Bonomo P, Petrucci A, Paiar F, Lastrucci L, Bonù ML, Greco D, Costa L, Pegurri L, Triggiani L, Belgioia L, Desideri I, Grisanti S, Buglione M, Magrini SM. Maddalo M, et al. Among authors: paiar f. Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):469-477. doi: 10.1016/j.ijrobp.2020.02.637. Epub 2020 Mar 14. Int J Radiat Oncol Biol Phys. 2020. PMID: 32184121 Clinical Trial.
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival.
Tonoli S, Magrini SM, Costa L, Paiar F, Simontacchi G, Scotti V, Pasinetti N, Barca R, Barbieri D, De Stefani A, Cellai E, Buglione M, Biti G. Tonoli S, et al. Among authors: paiar f. Radiol Med. 2012 Jun;117(4):690-714. doi: 10.1007/s11547-011-0755-9. Epub 2011 Nov 17. Radiol Med. 2012. PMID: 22095424
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance.
Mangoni M, Desideri I, Detti B, Bonomo P, Greto D, Paiar F, Simontacchi G, Meattini I, Scoccianti S, Masoni T, Ciabatti C, Turkaj A, Serni S, Minervini A, Gacci M, Carini M, Livi L. Mangoni M, et al. Among authors: paiar f. Biomed Res Int. 2014;2014:781340. doi: 10.1155/2014/781340. Epub 2014 Apr 30. Biomed Res Int. 2014. PMID: 24999475 Free PMC article. Review.
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma.
Pasqualetti F, Montemurro N, Desideri I, Loi M, Giannini N, Gadducci G, Malfatti G, Cantarella M, Gonnelli A, Montrone S, Visani L, Scatena C, Naccarato AG, Perrini P, Gambacciani C, Santonocito O, Morganti R, Paiar F. Pasqualetti F, et al. Among authors: paiar f. Acta Neurol Belg. 2022 Apr;122(2):441-446. doi: 10.1007/s13760-021-01765-4. Epub 2021 Aug 16. Acta Neurol Belg. 2022. PMID: 34396487
165 results